Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 21619550)

1.

Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage.

Lian F, Xing X, Yuan G, Schäfer C, Rauser S, Walch A, Röcken C, Ebeling M, Wright MB, Schmid RM, Ebert MP, Burgermeister E.

Biochem J. 2011 Sep 1;438(2):315-23. doi: 10.1042/BJ20102096.

2.

Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.

Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, Edwards PA.

J Biol Chem. 2002 Jan 25;277(4):2908-15. Epub 2001 Nov 12.

3.

Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.

Miyata M, Matsuda Y, Tsuchiya H, Kitada H, Akase T, Shimada M, Nagata K, Gonzalez FJ, Yamazoe Y.

Drug Metab Pharmacokinet. 2006 Aug;21(4):315-23.

4.

Bile salt excretory pump: biology and pathobiology.

Suchy FJ, Ananthanarayanan M.

J Pediatr Gastroenterol Nutr. 2006 Jul;43 Suppl 1:S10-6. Review.

PMID:
16819395
5.

Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase.

Matsukuma KE, Bennett MK, Huang J, Wang L, Gil G, Osborne TF.

J Lipid Res. 2006 Dec;47(12):2754-61. Epub 2006 Sep 6.

6.

Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation.

Zhang Y, Kast-Woelbern HR, Edwards PA.

J Biol Chem. 2003 Jan 3;278(1):104-10. Epub 2002 Oct 19.

7.

Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.

Xing X, Burgermeister E, Geisler F, Einwächter H, Fan L, Hiber M, Rauser S, Walch A, Röcken C, Ebeling M, Wright MB, Schmid RM, Ebert MP.

Hepatology. 2009 Mar;49(3):979-88. doi: 10.1002/hep.22712.

PMID:
19072826
8.

Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice.

Fiorucci S, Mencarelli A, Cipriani S, Renga B, Palladino G, Santucci L, Distrutti E.

Br J Pharmacol. 2011 Dec;164(8):1929-38. doi: 10.1111/j.1476-5381.2011.01481.x.

9.

Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.

Catalano S, Malivindi R, Giordano C, Gu G, Panza S, Bonofiglio D, Lanzino M, Sisci D, Panno ML, Andò S.

J Biol Chem. 2010 Feb 19;285(8):5581-93. doi: 10.1074/jbc.M109.052670. Epub 2009 Dec 21.

10.

The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.

Mencarelli A, Renga B, Migliorati M, Cipriani S, Distrutti E, Santucci L, Fiorucci S.

J Immunol. 2009 Nov 15;183(10):6657-66. doi: 10.4049/jimmunol.0901347. Epub 2009 Oct 30.

11.

Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor.

Jung D, Podvinec M, Meyer UA, Mangelsdorf DJ, Fried M, Meier PJ, Kullak-Ublick GA.

Gastroenterology. 2002 Jun;122(7):1954-66.

PMID:
12055601
12.

Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.

Qin P, Borges-Marcucci LA, Evans MJ, Harnish DC.

Am J Physiol Gastrointest Liver Physiol. 2005 Aug;289(2):G267-73. Epub 2005 Apr 7.

13.

Bile acid increases expression of the histamine-producing enzyme, histidine decarboxylase, in gastric cells.

Ku HJ, Kim HY, Kim HH, Park HJ, Cheong JH.

World J Gastroenterol. 2014 Jan 7;20(1):175-82. doi: 10.3748/wjg.v20.i1.175.

14.
15.

The amino acid residues asparagine 354 and isoleucine 372 of human farnesoid X receptor confer the receptor with high sensitivity to chenodeoxycholate.

Cui J, Heard TS, Yu J, Lo JL, Huang L, Li Y, Schaeffer JM, Wright SD.

J Biol Chem. 2002 Jul 19;277(29):25963-9. Epub 2002 May 9.

16.

Human kininogen gene is transactivated by the farnesoid X receptor.

Zhao A, Lew JL, Huang L, Yu J, Zhang T, Hrywna Y, Thompson JR, de Pedro N, Blevins RA, Peláez F, Wright SD, Cui J.

J Biol Chem. 2003 Aug 1;278(31):28765-70. Epub 2003 May 21.

17.

Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.

Claudel T, Inoue Y, Barbier O, Duran-Sandoval D, Kosykh V, Fruchart J, Fruchart JC, Gonzalez FJ, Staels B.

Gastroenterology. 2003 Aug;125(2):544-55.

PMID:
12891557
18.

FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine.

Lee H, Zhang Y, Lee FY, Nelson SF, Gonzalez FJ, Edwards PA.

J Lipid Res. 2006 Jan;47(1):201-14. Epub 2005 Oct 26.

19.

The bile acid receptor FXR is a modulator of intestinal innate immunity.

Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S.

J Immunol. 2009 Nov 15;183(10):6251-61. doi: 10.4049/jimmunol.0803978. Epub 2009 Oct 28.

20.

Antiatherosclerotic effect of farnesoid X receptor.

Mencarelli A, Renga B, Distrutti E, Fiorucci S.

Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H272-81. doi: 10.1152/ajpheart.01075.2008. Epub 2008 Nov 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk